In addition, mechanistic investigations have identified that NFATc2/SOX2 coupling can upregulate ALDH1A1 expression by binding to its 5′ enhancer, attenuate oxidative stress induced by cancer drug treatment, and lead to increased resistance to chemotherapy and targeted therapy.100. Here, ALDH1A1 is linked to cancer.